Microbot Medical Inc

Repligen Corporation develops novel therapeutics for the treatment of diseases of the central nervous and immune systems. It provides clinical development programs for the areas of schizophrenia, obsessive-compulsive disorder, bipolar disorder, multiple sclerosis and lupus. Repligen markets two niche products, Protein A and SecreFlo. Protein A is a consumable reagent used by the pharmaceutical industry to manufacture a class of drugs called monoclonal antibodies. The company offers a number of products based on recombinant Protein A, which include recombinant Protein A, Immobilized Protein A and Protein A ELISA Kits. SecreFlo is approved by the Food and Drug Administration to aid in the diagnosis of pancreatic exocrine dysfunction and gastrinoma and to aid in the identification and cannulation of the pancreatic ducts in patients undergoing endoscopic retrograde cholangiopancreatography. Repligen Corporation was established in 1981 and is headquartered in Waltham, Mass.

Millipore Research and Development is one of the leading providers of products and services to improve productivity in biopharmaceutical manufacturing and clinical, analytical and research laboratories. The company offers a range of products, such as blotting membranes, centrifugal filter units, environmental monitors, and filter holders and plates. Additionally, its product line includes filtration systems, fluid contamination kits, hazardous waste equipment, incubators and rapid microbiology systems. The company provides products for a variety of applications that include air and gas filtration, beverage processing, bioburden reduction, chromatography purification, disposable manufacturing and plasma fractionation. Millipore Research and Development employs more than 5,500 employees in over 47 offices worldwide. The company is located in Bedford, Mass., and is part of Millipore Corporation.

Sanofi Genzyme, a part of Sanofi's global specialty care business unit, is dedicated to addressing rare diseases, rare blood disorders, neurology, immunology, and oncology. With a focus on specialized care and innovative treatments, Sanofi Genzyme strives to make a meaningful impact on patients' lives worldwide. Generated from their website's infomation